Whitepaper: Venture Capital 101

Presenting the Venture Capital 101 whitepaper highlighting the background and basics of VC for potential investors.

continue reading >

Modulo Bio: Reprogramming Microglia to Treat Neurodegenerative Diseases

Modulo Bio has built a neuroimmune platform based on the integration of an iterative machine learning model and a clinically relevant cellular model which guides the discovery of novel disease-targeted neuroimmune therapeutics.

continue reading >

The Bioverge Podcast: Enlisting the Viral Immune System in the Fight Against Cancer

Anat Burkovitz, CEO of TrojanBio, sits down with Neil to discuss its AI-drive antibodies platform, how it enlists the viral immune system in the fight against cancer, and why she thinks the technology will broaden the population of patients who will benefit from immunotherapies.

continue reading >

The Bioverge Podcast: AI Derived Brain Biomarker for Precision Therapies

On the latest episode of The Bioverge Podcast, Amit Etkin, Founder and CEO of Alto Neuroscience, sits down with Neil Littman to discuss the lack of innovation in psychiatric medicines, how Alto has identified AI-derived brain biomarkers, and how that is fueling its pipeline of precision therapies to treat mental health disorders.

continue reading >

The Bioverge Podcast: Reengineering Healthcare and Medicine with Technology

Vineeta Agarwala, General Partner at Andreessen Horowitz and lead of the firm’s bio and health fund, sits down with Neil to discuss her investment process, how technology is transforming biotech and healthcare, and why she thinks drug development becoming more and more like software development.

continue reading >

The Bioverge Podcast: Unlocking the Potential of Genetic Medicines

David Kirn, Co-Founder and CEO of 4DMT, sits down with Neil to discuss the limits of existing AAV vectors and how his company is using its Therapeutic Vector Evolution platform to invent customized vectors that allows it to take a disease specific approach to unlock the potential of genetic medicines.

continue reading >

Neil Littman on The Scaling Up Podcast - Investing in the Future of Health

Neil is the Founder & CEO of Bioverge Ventures, an investment platform democratizing access to enable individuals to diversify their portfolio with private biotech and healthcare investments for the purposes of long-term wealth creation.

continue reading >

JelikaLite: A Home-Based, Non-Invasive Therapy for Children with Autism

JelikaLite has developed the first home-based, non-invasive stimulation device for children with autism. Known as Cognilum, it combines a wearable neurostimulation and EEG-sensing device with an AI-driven data platform in an integrated system to analyze developmental trajectory and personalize future treatments in a feedback loop.

continue reading >

The Bioverge Podcast: Making Medicines Affordable For Everyone

Peter Kolchinsky, Founder and Managing Director of RA Capital Management and Founder of the nonprofit No Patient Left Behind, sits down with Neil to discuss his book “The Great American Drug Deal,” policy fights over pricing, and his organization’s efforts to make medicines affordable for all Americans.

continue reading >

The Bioverge Podcast: Unleashing the Power of Gene Therapy for a Broad Universe of Diseases

Kriya Therapeutics Co-Founder, Chairman, and CEO Shankar Ramaswamy sits down with Neil to discuss how the company is changing the way gene therapies are designed, developed, and manufactured in an effort to cut costs, accelerate the time to market, and expand the reach of gene therapy to a broad universe of disease.

continue reading >
Investing

Whitepaper: Venture Capital 101

Presenting the Venture Capital 101 whitepaper highlighting the background and basics of VC for potential investors.

Continue Reading >
Health+Tech

Modulo Bio: Reprogramming Microglia to Treat Neurodegenerative Diseases

Modulo Bio has built a neuroimmune platform based on the integration of an iterative machine learning model and a clinically relevant cellular model which guides the discovery of novel disease-targeted neuroimmune therapeutics.

Continue Reading >
Podcast

The Bioverge Podcast: Enlisting the Viral Immune System in the Fight Against Cancer

Anat Burkovitz, CEO of TrojanBio, sits down with Neil to discuss its AI-drive antibodies platform, how it enlists the viral immune system in the fight against cancer, and why she thinks the technology will broaden the population of patients who will benefit from immunotherapies.

Continue Reading >
Podcast

The Bioverge Podcast: AI Derived Brain Biomarker for Precision Therapies

On the latest episode of The Bioverge Podcast, Amit Etkin, Founder and CEO of Alto Neuroscience, sits down with Neil Littman to discuss the lack of innovation in psychiatric medicines, how Alto has identified AI-derived brain biomarkers, and how that is fueling its pipeline of precision therapies to treat mental health disorders.

Continue Reading >
Podcast

The Bioverge Podcast: Reengineering Healthcare and Medicine with Technology

Vineeta Agarwala, General Partner at Andreessen Horowitz and lead of the firm’s bio and health fund, sits down with Neil to discuss her investment process, how technology is transforming biotech and healthcare, and why she thinks drug development becoming more and more like software development.

Continue Reading >
Podcast

The Bioverge Podcast: Unlocking the Potential of Genetic Medicines

David Kirn, Co-Founder and CEO of 4DMT, sits down with Neil to discuss the limits of existing AAV vectors and how his company is using its Therapeutic Vector Evolution platform to invent customized vectors that allows it to take a disease specific approach to unlock the potential of genetic medicines.

Continue Reading >
News & Media

Neil Littman on The Scaling Up Podcast - Investing in the Future of Health

Neil is the Founder & CEO of Bioverge Ventures, an investment platform democratizing access to enable individuals to diversify their portfolio with private biotech and healthcare investments for the purposes of long-term wealth creation.

Continue Reading >
Health+Tech

JelikaLite: A Home-Based, Non-Invasive Therapy for Children with Autism

JelikaLite has developed the first home-based, non-invasive stimulation device for children with autism. Known as Cognilum, it combines a wearable neurostimulation and EEG-sensing device with an AI-driven data platform in an integrated system to analyze developmental trajectory and personalize future treatments in a feedback loop.

Continue Reading >
Podcast

The Bioverge Podcast: Making Medicines Affordable For Everyone

Peter Kolchinsky, Founder and Managing Director of RA Capital Management and Founder of the nonprofit No Patient Left Behind, sits down with Neil to discuss his book “The Great American Drug Deal,” policy fights over pricing, and his organization’s efforts to make medicines affordable for all Americans.

Continue Reading >
Podcast

The Bioverge Podcast: Unleashing the Power of Gene Therapy for a Broad Universe of Diseases

Kriya Therapeutics Co-Founder, Chairman, and CEO Shankar Ramaswamy sits down with Neil to discuss how the company is changing the way gene therapies are designed, developed, and manufactured in an effort to cut costs, accelerate the time to market, and expand the reach of gene therapy to a broad universe of disease.

Continue Reading >
<< Previous